Cargando…

Glial Fibrillary Acidic Protein: A Biomarker and Drug Target for Alzheimer’s Disease

Glial fibrillary acidic protein (GFAP) is an intermediate filament structural protein involved in cytoskeleton assembly and integrity, expressed in high abundance in activated glial cells. GFAP is neuroprotective, as knockout mice are hypersensitive to traumatic brain injury. GFAP in cerebrospinal f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ganne, Akshatha, Balasubramaniam, Meenakshisundaram, Griffin, W. Sue T., Shmookler Reis, Robert J., Ayyadevara, Srinivas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322874/ https://www.ncbi.nlm.nih.gov/pubmed/35890250 http://dx.doi.org/10.3390/pharmaceutics14071354

Ejemplares similares

Intrinsically disordered proteins identified in the aggregate proteome serve as biomarkers of neurodegeneration
por: Ayyadevara, Srinivas, et al.
Publicado: (2021)

Machine-learning analysis of intrinsically disordered proteins identifies key factors that contribute to neurodegeneration-related aggregation
por: Ganne, Akshatha, et al.
Publicado: (2022)

Physiological Consequences of Targeting 14-3-3 and Its Interacting Partners in Neurodegenerative Diseases
por: Ganne, Akshatha, et al.
Publicado: (2022)

Aggregate Interactome Based on Protein Cross-linking Interfaces Predicts Drug Targets to Limit Aggregation in Neurodegenerative Diseases
por: Balasubramaniam, Meenakshisundaram, et al.
Publicado: (2019)

“Protein aggregates” contain RNA and DNA, entrapped by misfolded proteins but largely rescued by slowing translational elongation
por: Shmookler Reis, Robert J., et al.
Publicado: (2021)

A Novel Microtubule-Binding Drug Attenuates and Reverses Protein Aggregation in Animal Models of Alzheimer’s Disease
por: Kakraba, Samuel, et al.
Publicado: (2019)

In silico analysis of TUBA4A mutations in Amyotrophic Lateral Sclerosis to define mechanisms of microtubule disintegration
por: Ganne, Akshatha, et al.
Publicado: (2023)

Structural insights into pro-aggregation effects of C. elegans CRAM-1 and its human ortholog SERF2
por: Balasubramaniam, Meenakshisundaram, et al.
Publicado: (2018)

Protein homeostasis in the aged and diseased heart
por: Mainali, Nirjal, et al.
Publicado: (2023)

Proteins in aggregates functionally impact multiple neurodegenerative disease models by forming proteasome-blocking complexes
por: Ayyadevara, Srinivas, et al.
Publicado: (2015)

Computational target-based drug repurposing of elbasvir, an antiviral drug predicted to bind multiple SARS-CoV-2 proteins
por: Balasubramaniam, Meenakshisundaram, et al.
Publicado: (2020)

PIP(3)-binding proteins promote age-dependent protein aggregation and limit survival in C. elegans
por: Ayyadevara, Srinivas, et al.
Publicado: (2016)

Proteins that mediate protein aggregation and cytotoxicity distinguish Alzheimer's hippocampus from normal controls
por: Ayyadevara, Srinivas, et al.
Publicado: (2016)

Apolipoprotein E4 inhibits autophagy gene products through direct, specific binding to CLEAR motifs
por: Parcon, Paul A., et al.
Publicado: (2017)

Thiadiazolidinone (TDZD) Analogs Inhibit Aggregation-Mediated Pathology in Diverse Neurodegeneration Models, and Extend C. elegans Life- and Healthspan
por: Kakraba, Samuel, et al.
Publicado: (2023)

Clinical and biological relevance of glial fibrillary acidic protein in Alzheimer’s disease
por: Yang, Zhengshi, et al.
Publicado: (2023)

Proteins that accumulate with age in human skeletal-muscle aggregates contribute to declines in muscle mass and function in Caenorhabditis elegans
por: Ayyadevara, Srinivas, et al.
Publicado: (2016)

Modelling and Characterization of Glial Fibrillary Acidic Protein
por: Deka, Hemchandra, et al.
Publicado: (2015)

Autoimmune glial fibrillary acidic protein astrocytopathy
por: Kunchok, Amy, et al.
Publicado: (2019)

Clinical utility of serum glial fibrillary acidic protein in glial neoplasm
por: Yadav, Nidhi, et al.
Publicado: (2022)

Glial Fibrillary Acidic Protein as Biomarker Indicates Purity and Property of Auricular Chondrocytes
por: Nishizawa, Satoru, et al.
Publicado: (2020)

Glial Fibrillary Acidic Protein (GFAP): Neuroinflammation Biomarker in Acute Ischemic Stroke
por: Amalia, Lisda
Publicado: (2021)

Glial fibrillary acidic protein in tumours of the nervous system.
por: Delpech, B., et al.
Publicado: (1978)

Glial fibrillary acidic protein is localized in the lens epithelium
Publicado: (1984)

Serum glial fibrillary acidic protein as a biomarker of brain injury in premature neonates
por: Metallinou, Dimitra, et al.
Publicado: (2022)

Serum Glial Fibrillary Acidic Protein: A Neuromyelitis Optica Spectrum Disorder Biomarker
por: Aktas, Orhan, et al.
Publicado: (2021)

Association of plasma glial fibrillary acidic protein (GFAP) with neuroimaging of Alzheimer's disease and vascular pathology
por: Shir, Dror, et al.
Publicado: (2022)

Real-world applicability of glial fibrillary acidic protein and neurofilament light chain in Alzheimer’s disease
por: Parvizi, Tandis, et al.
Publicado: (2022)

A Small-Molecule Inhibitor of RAD51 Reduces Homologous Recombination and Sensitizes Multiple Myeloma Cells to Doxorubicin
por: Alagpulinsa, David A., et al.
Publicado: (2014)

Quantitation of glial fibrillary acidic protein in human brain tumours.
por: Rasmussen, S., et al.
Publicado: (1980)

Glial Fibrillary Acidic Protein-Expressing Glia in the Mouse Lung
por: Suarez-Mier, Gabriela B., et al.
Publicado: (2015)

Parainfectious Anti-Glial Fibrillary Acidic Protein-Associated Meningoencephalitis
por: Joo, Jae Young, et al.
Publicado: (2022)

Elevated vitreous body glial fibrillary acidic protein in retinal diseases
por: Jünemann, Anselm Gerhard Maria, et al.
Publicado: (2015)

Positive Feedback between Transcriptional and Kinase Suppression in Nematodes with Extraordinary Longevity and Stress Resistance
por: Tazearslan, Çagdaþ, et al.
Publicado: (2009)

Extreme Depletion of PIP(3) Accompanies the Increased Life Span and Stress Tolerance of PI3K-null C. elegans Mutants
por: Bharill, Puneet, et al.
Publicado: (2013)

Increased Glial Fibrillary Acid Protein and Vimentin in Vitreous Fluid as a Biomarker for Proliferative Vitreoretinopathy
por: Lee, Sun Young, et al.
Publicado: (2020)

Glial Fibrillary Acidic Protein in Blood as a Disease Biomarker of Neuromyelitis Optica Spectrum Disorders
por: Kim, Hyunjin, et al.
Publicado: (2022)

Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer’s disease
por: Chatterjee, Pratishtha, et al.
Publicado: (2021)

Blood Levels of Glial Fibrillary Acidic Protein (GFAP) in Patients with Neurological Diseases
por: Mayer, Christoph A., et al.
Publicado: (2013)

Overlapping Autoimmune Syndromes in Patients With Glial Fibrillary Acidic Protein Antibodies
por: Yang, Xinguang, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_det4h88vcgsi2fspntle2b7iok